Dataset Information


Lactobacillus reuteri DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis.

ABSTRACT: Atopic Dermatitis (AD) is a chronically relapsing skin condition characterized by dry, itchy, and inflamed skin where sufferers can frequently be subject to infections. Probiotics are known to be potent immune-modulators, and live Lactobacillus reuteri DSM 17938 has shown to be anti-inflammatory but also to possess antimicrobial and barrier function properties. This study aimed to investigate and compare two investigational ointment products (topical probiotic and control) for cutaneous acceptability, safety, and efficacy under normal conditions of use, in adult subjects with atopic dermatitis. The products were applied twice daily for 8 weeks, and cutaneous acceptability, SCORAD index, local SCORAD, and adverse events were evaluated after 4 and 8 weeks of treatment. At the end of the observations, it was demonstrated that both the probiotic-containing and probiotic-free ointments were both cutaneously acceptable and safe. It importantly showed a statistically and clinically significant improvement of the SCORAD index and local SCORAD in adult subjects with AD after 4 and 8 weeks of continuous use. In conclusion, we show evidence that the probiotic product, containing live L. reuteri DSM 17938 as an extra ingredient, is safe and promising as a novel topical cosmetic ointment and with further testing could be a standard topical product for the management of atopic dermatitis or other disorders associated with the skin.


PROVIDER: S-EPMC7409218 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7465198 | BioStudies
2020-01-01 | S-EPMC7601218 | BioStudies
2019-01-01 | S-EPMC6490491 | BioStudies
2017-01-01 | S-EPMC5622725 | BioStudies
2017-01-01 | S-EPMC6336100 | BioStudies
2018-01-01 | S-EPMC5833582 | BioStudies
2019-01-03 | GSE124550 | GEO
2012-01-01 | S-EPMC3504569 | BioStudies
2020-01-01 | S-EPMC7035999 | BioStudies
2019-01-01 | S-EPMC6590358 | BioStudies